Calendar

Week of Apr 17, 2023

Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

Apr 18, 2023approval1212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

Apr 18, 2023approval1212d agoPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

Apr 19, 2023approval1211d agoPOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approvalpolatuzumab vedotin

Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS

Apr 20, 2023approval1210d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

Apr 20, 2023approval1210d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

Apr 21, 2023approval1209d agoPEMETREXED DISODIUM — FDA approvalAlimta

Sponsor: SANDOZ. Form: SOLUTION. Route: INTRAVENOUS

Apr 24, 2023approval1206d agoZEGERID OTC (OMEPRAZOLE) — FDA approvalCovis Pharmaceuticals Inc (Inactive)

Sponsor: RILEY CONSUMER. Form: CAPSULE. Route: ORAL

Apr 25, 2023approval

May 1, 2023approval1199d agoDALFAMPRIDINE — FDA approvaldalfampridine ER

Sponsor: ACCORD HLTHCARE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

May 1, 2023approval

May 8, 2023approval1192d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS

May 8, 2023approval

← prev

page 1 of 118